| 000 | 01612 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515202159.0 | ||
| 264 | 0 | _c20100309 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a0946-1965 | ||
| 024 | 7 |
_a10.5414/cpp48076 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPerkovic, O | |
| 245 | 0 | 0 |
_aSildenafil induced choreoathetosis in men with Parkinson's disease. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology and therapeutics _cJan 2010 |
||
| 300 |
_a76-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAntiparkinson Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAthetosis _xchemically induced |
| 650 | 0 | 4 |
_aCarbidopa _xtherapeutic use |
| 650 | 0 | 4 |
_aChorea _xchemically induced |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevodopa _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aParkinson Disease _xcomplications |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aPiperazines _xadverse effects |
| 650 | 0 | 4 |
_aPurines _xadverse effects |
| 650 | 0 | 4 | _aSildenafil Citrate |
| 650 | 0 | 4 |
_aSulfones _xadverse effects |
| 700 | 1 | _aVitezic, D | |
| 700 | 1 | _aRudez, J | |
| 700 | 1 | _aVitezic, M | |
| 700 | 1 | _aKovacevic, M | |
| 700 | 1 | _aMrsic-Pelcic, J | |
| 700 | 1 | _aLjubicic, D | |
| 700 | 1 | _aJurjevic, A | |
| 773 | 0 |
_tInternational journal of clinical pharmacology and therapeutics _gvol. 48 _gno. 1 _gp. 76-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5414/cpp48076 _zAvailable from publisher's website |
| 999 |
_c19420148 _d19420148 |
||